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Antenatal exposure to maternal stress is a factor that may impact on offspring cognitive 
development. While some evidence exists of an association between maternal antenatal 
depressive or anxiety symptoms and infants’ cognitive outcomes, less is known about the role of 
biological indices of maternal antenatal stress in relation to infant cognitive development. The 
current study investigated the association between maternal depressive and anxiety symptoms, 
stress and inflammatory markers during pregnancy and infant’s cognitive development in a sample 
of 104 healthy pregnant women (mean gestational age=34.76; SD=1.12) and their 12-week-old 
infants (mean postnatal weeks=11.96; SD=1.85). Maternal depressive and anxiety symptoms were 
evaluated during pregnancy, alongside measurements of serum Interleukin-6 (IL-6), C-Reactive 
Protein (CRP), salivary cortisol and alpha amylase (sAA) concentrations. Infant cognitive 
development, maternal caregiving and concurrent anxiety or depressive symptoms were assessed 
12 weeks after delivery. Hierarchical linear regressions indicated that higher maternal diurnal 
cortisol and CRP levels were independently associated with lower infant cognitive development 
scores, while adjusting for infant gender and gestational age, maternal IQ, caregiving, depressive 
or anxiety symptoms. Though correlational, findings seem suggestive of a role for variation in 
maternal biological stress signals during pregnancy in influencing infants’ early cognitive 
development.  
 













1. Introduction  
 
Healthy cognitive development is an important contributor to an individual’s long-term life 
chances, influencing future academic performance, social competence and mental health (e.g., 
Peet et al., 2015; Gale, Hatch, Batty, & Deary, 2009). Although cognitive development shows 
substantial genetic influence (e.g., Kirkpatrick, McGue, Iacono, Miller, & Basu, 2014), there has 
been a growing appreciation of the role of early environmental exposures in shaping brain 
development and influencing cognitive outcomes, with increasing attention directed toward 
prenatal exposures (Grossman et al., 2003). In particular, antenatal exposure to maternal stress is 
one factor that may influences offspring development across several domains, including the 
cognitive domain (Van den Bergh et al., 2017). Several community-based studies have 
investigated the effects of maternal psychological distress experienced during pregnancy, such as 
depressive or anxiety symptoms, on children’s cognitive development (reviewed in Van den Bergh 
et al., 2017). Antenatal maternal depression has been shown to be associated with poorer infant 
cognitive development in a number of studies (e.g., Deave, Heron, Evans, & Emond,  2008; Koutra 
et al., 2013; Evans et al., 2012), although positive associations (Di Pietro, Novak, Costigan, Atella, 
& Reusing, 2006), as well as null associations (Tse et al., 2010; Nulman et al., 2012; Keim et al., 
2011) have also been reported. Likewise, maternal anxiety during pregnancy was associated with 
lower cognitive scores in offspring in some studies (e.g., Ibanez et al., 2015; Keim et al., 2011; 
Davis & Sandman, 2010), though not all (Grant, McMahon, Reilly, & Austin, 2010; Plamondon et 
al., 2015). A recent meta-analysis indicates a very modest negative association (r=−0.05), between 
maternal antenatal stress or anxiety and infant cognitive development, although the effect size 
varied widely across studies and was stronger for objective indices of maternal stress (e.g., major 
life events) and for retrospective assessment of maternal antenatal stress (Tarabulsy et al., 2014). 
Thus, while the association between maternal antenatal anxiety or depression and child cognitive 
development has been well investigated, the weight of supporting evidence is not yet convincing. 
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Biological measures of maternal stress might better reflect not only the women’s experience of 
stress during pregnancy but also directly assess the potential biological mechanisms involved that 
influence fetal development. However, to date, the influence of variation in biological indices of 
maternal antenatal stress on offspring’s cognitive development has received relatively limited 
investigation.  
Cortisol, the end product of the Hypothalamic-Pituitary-Adrenal (HPA) axis, has been the 
most studied biomarker in relation to the effects of antenatal maternal stress on fetal development. 
Cortisol plays an essential role in supporting fetal growth and brain development (Lupien, McEwen, 
Gunnar, & Heim, 2009). However, prenatal exposure to excessive glucocorticoid levels, both 
synthetic and endogenous, during sensitive developmental periods, can have detrimental effects 
on fetal brain development, especially in regions rich in cortisol receptors, and can interfere with 
synaptogenesis and neurotransmitter function (Coe & Lubach, 2005). Fetal cortisol exposure is 
regulated by the activity of the placental enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-
HSD2), which provides partial protection for the fetus from maternal cortisol (Gitau, Cameron, Fisk, 
& Glover, 1998). It has been hypothesized that stress-linked elevations in maternal cortisol or 
impairment of the activity of 11β-HSD2, might lead to more cortisol passing through the placenta 
and directly affecting fetal development (O’Donnell and Meaney, 2017). Few studies have 
examined the association between endogenous maternal cortisol across gestation and infants’ 
cognitive outcomes and these have yielded mixed findings. Higher maternal cortisol in late 
pregnancy was associated with lower infant cognitive scores at 3 months (Huizink, Robles de 
Medina, Mulder, Visser, & Buitelaar, 2003), 17 months (Bergman, Sarkar, Glover, & O’Connor, 
2010) and 7 years (LeWinn et al., 2009), but one study found no association (assessed at 8 
months, see Huizink et al., 2003). Davis and Sandman (2010) also reported a negative association 
between higher maternal cortisol early in gestation and lower mental development at 12 months, 
but not at 3 and 6 months, and, to complicate the picture further, a positive association was found 
when maternal cortisol was assessed in late pregnancy. Furthermore, higher maternal cortisol in 
late pregnancy, but not earlier, predicted greater cortical thickness in frontal regions and better 
cognitive functioning in the children at 6-9 year of age (Davis, Head, Buss, & Sandman, 2017). 
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Significant differences in how cortisol is assessed across studies is likely important in explaining 
these inconsistent findings. Collecting multiple diurnal cortisol measures is generally thought to 
better reflect maternal stress experience (Harville et al., 2009) and more reliably estimate the total 
diurnal cortisol output (Adam and Kumari, 2009). However, multiple cortisol measurements have 
not been employed in many previous studies (exception was one small study (N=30) from 
Haselbeck et al., 2017).  
Very little is known about the influence of alternative biomarkers of maternal antenatal 
stress on offspring. For example, it has been hypothesized that stress-related activation of the 
Sympathethic Nervous System (SNS) might affect utero-placental blood flow (Merlot, Couret, & 
Otten, 2008) and, indirectly, foetal development (Rakers et al., 2017). Salivary alpha amylase 
(sAA), a non-invasive marker of SNS activity (Nater & Rohleder, 2009), has been found to be 
associated with infant birth weight (Nazzari et al., 2019; Giesbrecht et al., 2015), which in turn, is a 
well-established predictor of later cognitive abilities (e.g. Shenkin, Starr, & Deary, 2004). However, 
the association between maternal antenatal sAA levels and infant cognitive development has not 
yet been investigated.  
Likewise, it is now well-established that stress is associated with changes in immune 
system functioning, including increased levels of inflammatory markers such as Interleukine-6 (IL-
6) and C-reactive protein (CRP), both in non-pregnant (e.g., Segerstrom & Miller, 2004) and 
pregnant (e.g. Christian et al., 2012) samples. Furthermore, maternal antenatal inflammation is 
increasingly recognized as a factor that may influence offspring development (Gumusoglu & 
Stevens, 2019). Neverthless, research in humans is at an early stage (Nazzari & Frigerio, 2019). 
Elevated maternal IL-6 or CRP levels during pregnancy have been linked with adverse pregnancy 
and birth outcomes (Christian, 2012) and with new-born functional and structural brain alterations 
(e.g. ,Graham et al., 2018; Rudolph et al., 2018). Only two studies have examined the role of 
maternal antenatal inflammation on infant cognitive development. Rasmussen and colleagues 
(2019) found that higher maternal IL-6 levels were associated with poorer cognitive development at 
12-months, whereas Spann and colleagues (2018) reported a positive association between 
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maternal IL-6 and CRP levels in late pregnancy and 14-month-olds’ cognitive development in a 
small sample of 36 adolescent mothers.   
 
1.1 Current study  
There is a growing recognition for a role of maternal antenatal stress signals in influencing 
fetal development and for possible long-lasting effects of such exposures on cognitive outcomes. 
However, existing studies have been characterized by a number of limitations. First, few 
prospective studies have combined multiple psychological and biological stress measures and 
most studies have focused on cortisol as a biomarker of maternal stress experience, while 
alternative biomarkers of stress or inflammation have been largely neglected. We therefore have 
only a limited picture of the spectrum of biological processes that may be involved in antenatal 
stress effects on cognitive development, or the relative independence or degree of overlap 
between different biological indicators and their association with cognitive outcomes. Secondly, 
almost all existing studies rely on single maternal cortisol sampling which does not allow for a 
reliable estimate of overall diurnal cortisol production. Third, available results are often beset by 
inconsistent inclusion of key confounders in the analyses. Specifically, because cognitive abilities 
are substantially heritable (e.g., Kirkpatrick et al., 2014) and may also correlate with social risk 
factors like low parental education, it is important to control for the role of maternal IQ, something 
that is rarely done in the field. Likewise, despite evidence indicating an important role for maternal 
early caregiving on infants’ cognitive development (e.g., Mills-Koonce et al., 2015), existing studies 
rarely account for the quality of early post-natal mother-infant relationship, thus limiting the 
inferences that can be made about programming effects of the prenatal environment. 
The current study contributes to the literature by investigating the influence of variation in 
maternal self-reported depressive and anxiety symptoms, stress hormones and inflammatory 
markers in late pregnancy on infant cognitive outcomes, controlling for maternal IQ, postnatal 
symptomatology and caregiving. We hypothesized that infants born to mothers with higher 
depressive or anxiety symptoms during pregnancy would show poorer cognitive performance than 
infants of mothers with lower symptoms. Furthermore, we predicted that higher maternal antenatal 
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diurnal cortisol would be related to lower cognitive scores. We made no a priori predictions for an 
association between maternal sAA levels or inflammatory markers and infants’ outcomes due to 
limited available literature.   
 
2 Material and methods 
 
2.1 Participants and procedure 
One hundred and ten women were recruited between 30th and 33rd weeks of gestation as 
part of the Effects of Depression on Infants (EDI) Study and followed longitudinally until 12 weeks 
post-delivery. Prenatal inclusion criteria were: aged 18-45 years, normotensive, with singleton 
uncomplicated pregnancy, non-smoker, not affected by any disease or taking any chronic 
medications, and with no current substance/alcohol abuse problems or psychiatric disorders 
(except for depression and anxiety) as ascertained through the Structured Clinical Interview for 
DSM-IV-TR Axis I Disorders (SCID-I; First, Spitzer, Gibbon, & Williams, 2002). Additionally, only 
healthy full term (or late preterm >35 weeks) infants were included in the current study. Six women 
were excluded because of: intrauterine death (N=1), newborn health problems (N=2) and missing 
infant developmental data (N=3), thus the final sample consisted of 104 mother-infant dyads. 
Women were mostly Italian (97.2%), middle-upper class (87.5%) and primiparous (91.3%). Infants 
(51% males) were mostly delivered vaginally (81.7%) at 39.44 mean gestational age (SD=1.25). 
Women who were excluded from the postnatal assessment did not differ from participants on any 
demographic variables, depression or anxiety scores. Around 17% of women scored equal or 
above the cut-off of 10 at the Edinburgh Postnatal Depression Scale (EPDS, Benvenuti et al., 
1999) and 24% of women scored equal or above the cut–off of 40 at the state anxiety subscale of 
the State-Trait Anxiety Inventory (STAI-S, Spielberger et al., 1970). Furthermore, 4.8% of women 
had a major depressive episode and 2,9% had an anxiety disorder during pregnancy as 
ascertained through the SCID-I.   
Maternal depressive and anxiety symptoms were evaluated between 34-36 gestational 
weeks (mean gestational age=34.76; SD=1.12), jointly with maternal cognitive function and 
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biomarkers levels. Infant cognitive development, maternal caregiving and concurrent anxiety or 
depressive symptoms were assessed 12 weeks after delivery (mean postnatal weeks=11.96; 
SD=1.85). 
The Ethics Committee of Scientific Institute Eugenio Medea and of University College 
London approved the study protocol and all mothers signed an informed written consent to 
participate.  
 
2.2 Maternal assessment 
Psychological distress. Depressive symptoms were evaluated through the Italian version 
(Benvenuti et al., 1999) of the 10-item Edinburgh Postnatal Depression Scale (EPDS; Cox, Holden, 
& Sagovsky, 1987), the most widely used self-report questionnaire to assess perinatal depressive 
symptoms on a 4-point Likert scale. Anxiety symptoms were evaluated on a 4-point Likert scale 
through the Italian version (Pedrabissi & Santinello, 1989) of the 20-item state anxiety subscale of 
the State-Trait Anxiety Inventory (STAI) (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1970).  
Cognitive function was evaluated through the Raven’s Standard Progressive Matrices 
(RSPM, Raven & Court, 1998), a widely employed test that assesses non-verbal general cognitive 
ability through 60 multiple choice items. Test time was limited to 30 minutes.  
Stress and inflammatory biomarkers. All women provided six saliva samples on two 
consecutive days upon awakening, 30 minutes post-waking and before going to bed. Samples 
were assayed for cortisol in duplicate using a competitive high sensitivity enzyme immunoassay kit 
(Expanded Range High Sensitivity Cortisol EIA Kit, Salimetrics) and for sAA using a kinetic 
enzyme assay kit (Salimetrics α-Amylase Kinetic Enzyme Assay Kit). One 30-min post-waking 
sample collected more than one hour from awakening was excluded from analyses (e.g., O’Connor 
et al. 2014). Daily average cortisol and sAA were calculated as the area under the curve (AUCg) 
using the trapezoid method with respect to the ground (Pruessner, Kirschbaum, Meinlschmid, & 
Hellhammer, 2003) for each day separately and the mean of the two days was used as the two 
values were highly correlated (r=0.58, p<.001, for cortisol, r=0.74, p<.001 for sAA). Antecubital 
venous blood samples were collected in the morning. Serum CRP and IL-6 concentrations were 
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assayed in duplicate by using Quantikine High Sensitivity ELISA kits (R&D Systems Europe, LTD). 
Ninety-one women out of 104 (87.5%) agreed to blood sampling during pregnancy. For further 
details see Nazzari et al., 2019. 
Caregiving behaviors were evaluated using the Emotional Availability (EA) Scales, 
Infancy/Early Childhood Version (4th edition, Biringen, 2008) during a 15 minute-videotaped free-
play session. The EA scales comprise four maternal parenting dimensions (Sensitivity, Structuring, 
Non-intrusiveness and Non-hostility) rated on a 7-point scale. As the four maternal EA scales were 
moderately inter-correlated (rs=0.50–0.73), they were standardized and summed to create an 
overall index of maternal EA (Cronbach’s α=.85) as previously reported (Taylor-Colls & Fearon, 
2015). Two trained clinical psychologists independently coded the videotaped interactions after the 
end of data collection. Both raters were blind to prenatal and postnatal data. A subsample of 20 
(19.5%) randomly chosen dyads were coded by both raters and showed high inter-rater 
consistency with intra-class correlation (ICC) coefficients ranging from .75 to .91 and a mean ICC 
of .84 (p<.001). 
 
2.3 Infant assessment 
Cognitive development was assessed through the Bayley Scales of Infant and Toddler 
Development – Third Edition (Bayley III, Bayley 2006), a well-standardized and widely employed 
developmental assessment, by a trained clinical psychologist blind to prenatal data. The Cognitive 
Scale measures sensorimotor integration, attention, habituation and memory, as well as interest in 
and understanding of the environment. Age-standardized composite scores were calculated by 
using test norms (mean=100; SD=15).  
 
2.4 Statistical analyses 
Variables were first examined for outliers and skewness. The distributions of the biological 
markers were positively skewed even after removing samples greater than 3 SD from the mean 
(n=7 samples for cortisol, n=4 for sAA, n=3 for IL-6), thus measures were natural log transformed 
prior to analysis to approximate normal distributions. Potential confounders of the relationship 
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between maternal prenatal variables and infants’ outcomes were examined through preliminary 
Pearson correlations and univariate analysis of variance (ANOVA). Separate hierarchical 
regression analyses were performed to evaluate the effects of maternal variables on infant’s 
cognitive scores. Covariates were entered in the first step. Maternal depression/anxiety scores 
were entered in a second step to assess the independent effect of prenatal maternal self-reported 
symptoms on infant outcomes, while biological markers concentrations were included in a third 
step to evaluate the unique contribution of maternal stress biomarkers to infant outcomes. Non-
linearity of the observed associations was examined by the inclusion of a quadratic term within the 
regression models. As maternal depression and anxiety were highly correlated both prenatally 
(r=0.66, p<.001) and postnatally (r=.58, p<.001), they were entered separately in subsequent 
analyses in order to avoid multicollinearity. Analyses including maternal anxiety rather than 
depression yielded comparable results and are reported in Supplementary Table 1. Lastly, we 
repeated analyses after excluding women with CRP levels above 10mg/L (N=5), since such levels 
could be due to subclinical acute infections and not reflect chronic inflammation (e.g. Wu et al., 
2002; Belo et al., 2005).   
The final sample size was 104 for analyses on the association between maternal stress 
markers (i.e. cortisol and sAA) and infant outcomes and 91 for analyses on the association 
between maternal inflammatory markers (i.e. IL-6 and CRP) and infant outcomes. Statistical 
analyses were performed using SPSS 24. 
 
3 Results  
 
3.1 Descriptive analyses and confounders 
Descriptive statistics for all study variables are presented in Table 1 using raw values. As 
displayed in Table 2, preliminary unadjusted bivariate correlations among study variables showed 
weak associations between maternal depressive or anxiety symptoms and biomarkers levels (r’s 
range= -.14-.19). In contrast, a modest negative association was found between maternal 
antenatal cortisol and infants’ cognitive scores (r=-.26).   
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Variables examined as potential confounders included sociodemographic factors (i.e., 
maternal age, education, SES, parity, infants’ age),  health-related factors (i.e., mode of delivery, 
length of labor, gestational age, birth weight, head circumference, actual weight, postnatal smoke 
exposure, breastfeeding versus formula-feeding), maternal EA and IQ. Gestational age at birth, 
maternal EA and IQ were modestly associated with infants’ cognitive performances (r’s range=.21-
.24), thus they were retained as covariate in subsequent models. As sex-differences in the 
association between prenatal maternal stress and infants’ cognitive outcomes have been reported 
(e.g., Loomans et al., 2012), all subsequent analyses controlled for infant gender. Furthermore, as 
an association between maternal postnatal depression and infant cognitive outcomes has been 
reported (Liu et al., 2017), maternal concurrent symptoms were included as confounders in all 
regression models. Models were performed both with and without the inclusion of postnatal 
symptoms. Adjusting for maternal depressive or anxiety symptoms at 3 months did not affect the 
statistical significance and direction of the association between prenatal maternal variables and 
infant outcomes in any of the analyses presented below.  
 
3.2 Prenatal maternal influences and infant’s cognitive development  
As shown in Table 3, hierarchical regression models revealed significant associations 
between higher maternal antenatal diurnal cortisol levels and lower cognitive scores at 3-months 
(β=-.37, t= -3.87, p<.001), while adjusting for infant gender, gestational age, maternal IQ, EA, pre- 
and postnatal depression. Similarly, maternal antenatal CRP levels were significantly negatively 
associated with infant cognitive development (β=-.22, t= -2.05, p=.04). In contrast, no effect of 
maternal antenatal depression on infant cognitive scores was found. 
Supplementary analyses indicated that the direction and statistical significance of the 
association between maternal cortisol and CRP levels during pregnancy and infant cognitive 
development remained substantially unchanged once all the biomarkers were included in a final 
regression model (respectively, β=-.32, t= -2.96, p=.004; β=-.23, t= -2.14, p=.04), thus suggesting 
that both biomarkers contribute significantly and independently to infant cognitive scores. 
Furthermore, in order to examine the existence of non-linear associations between maternal 
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biomarkers and infant cognitive outcomes, we repeated all the analyses including a quadratic term 
for maternal cortisol and CRP. When added to the models, centered second order polynomials of 
cortisol or CRP were not significantly associated with infant cognitive scores (respectively, β= -
.004, t= -0.04, p=.97; β=.11, t=0.98, p=.33), thus indicating that the observed association between 
maternal biomarkers and infant cognitive outcomes was linear.  Lastly, the main effect of maternal 
antenatal CRP levels on infant cognitive scores (β= -.24, t= -2.26, p=.027) remained significant 
when women with possible acute infections (CRP > 10.0 mg/L) were excluded.  
 
4. Discussion 
The current study sought to extend existing literature on the programming role of maternal 
antenatal stress in infant cognitive development by combining multiple psychological and biological 
stress markers and controlling for key confounders of the association. Normative variations in 
maternal diurnal cortisol and inflammation during pregnancy were independently and linearly 
associated with individual differences in 3-month-olds’ cognitive development. Importantly, the 
observed associations were found when controlling for maternal IQ, caregiving, infant gender and 
gestational age and were independent of antenatal and postnatal anxiety and depression. In 
contrast, maternal depressive or anxiety symptoms were not significantly associated with infants’ 
cognitive scores.  
In line with our predictions, we observed lower cognitive scores in infants whose mothers 
had higher levels of antenatal diurnal cortisol. Using multiple diurnal sampling, the present results 
support and extend the limited available literature linking higher levels of maternal endogenous 
cortisol in late pregnancy with poorer infant cognitive development (Huiznik et al., 2003; Bergman 
et al., 2010; LeWinn et al., 2009). The pathways underlying the observed association are still 
unclear. Though essentially correlational in nature, findings are consistent with animal evidence of 
neuro-motor and learning deficits in prenatally stressed offspring (Owen, Andrews, & Matthews, 
2005) and with studies linking prenatal glucocorticoid administration to reduced cognitive abilities 
and cortical thinning (Davis et al., 2013), and might suggest a role of maternal antenatal cortisol in 
influencing fetal brain development. As the expression of the 11β-HSD2 enzyme is reduced in the 
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last stages of gestation (Murphy, Smith, Giles, & Clifton, 2006), even mild elevations in maternal 
cortisol in late pregnancy might affect fetal brain development, particularly in regions sensitive to 
excessive levels of glucocorticoids such as the hippocampus (Noorlander et al., 2006), potentially 
leading to cognitive and behavioral alterations. Furthermore, maternal cortisol might influence fetal 
brain development indirectly by affecting placental blood vessel tone and leading to reduced utero-
placental blood flow. However, the observed association could also be explained by shared 
predictors of prenatal maternal cortisol and infant development, such as maternal diet or genetic 
factors, which were not measured in the current study.   
We also obtained evidence of an association between higher maternal CRP levels in late 
pregnancy and poorer infant cognitive development. Accumulating evidence from animal models 
suggests that maternal antenatal inflammation can influence the earliest stages of brain 
development and be responsible of altered neurodevelopmental outcomes in the offspring 
(reviewed in Gumusoglu & Stevens, 2019). More specifically,  preclinical studies of rodents and 
non-human primates have shown that activating the maternal immune system during pregnancy 
can affect brain myelination (Cai, Pan, Pang, Evans, & Rhodes, 2000), alter a widespread set of 
brain regions, such as the hippocampus, prefrontal cortex, mid-temporal and parietal lobe (e.g., 
Patterson, 2002; Golan et al., 2005; Bland et al., 2010; Short et al., 2010) and lead to behavioral 
disturbances, including learning, attention and memory deficits (e.g., Bilbo et al., 2008; Patterson, 
2009). Our findings of an association between higher third trimester maternal inflammation and 
poorer infant cognitive outcomes are in line with this body of evidence. However, it is worthwhile 
noting that while preclinical studies traditionally defined maternal immune activation as measured 
levels of inflammatory markers exceeding normal range, the association reported here remained 
strong and significant once women with CRP levels above 10 mg/L, possibly indicating acute 
infections (e.g. Wu et al., 2002), were excluded, thus suggesting that even modest and 
subthreshold variations in maternal inflammation might be associated with individual variation in 
early post-natal cognitive function in humans.  
The current results converge with initial evidence linking maternal antenatal inflammation with 
poorer neurobehavioral function at 6 days of age (Osborne et al., 2018) and poorer cognitive 
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development at 12 months (Rasmussen et al., 2019). Interestingly, structural and functional brain 
alterations (Graham et al., 2018; Rasmussen et al., 2019) and smaller head circumference at birth 
(Nazzari et al., 2019) have been found in newborns prenatally exposed to higher maternal IL-6 
levels, thus possibly suggesting that naturally occurring variations in antenatal levels of maternal 
inflammation could influence fetal brain development, although the mechanisms underlying this 
effect are still unknown. It is noteworthy that, despite the fact that both CRP and IL-6 are 
biomarkers of chronic or systemic low-grade inflammation (Rohleder, Aringer, & Boentert, 2012) 
and were correlated in the current sample, maternal antenatal IL-6 concentrations were not 
associated with 3-month-olds’ cognitive outcomes. These differences might be related to 
methodological issues, such as differential sensitivity of CRP and IL-6 to processing and storage 
conditions (Skogstrand et al., 2008). However, they might also be suggestive of distinct 
inflammatory pathways involved in fetal programming that deserve further investigation. For 
example, heightened maternal CRP levels could interfere with fetal growth and brain development 
by contributing to vascular and placental dysfunction (Ernst et al., 2011) or by directly altering 
offspring’s synaptic connectivity (Canetta et al., 2014). Secondly, higher CRP levels may indicate 
poor maternal health (Wium-Andersen & Nielsen, 2013), which can itself influence offspring brain 
development (Chittleborough, Lawlor, & Lynch, 2012) and, therefore, could potentially account for 
the current findings. Third, animal studies indicate that epigenetic mechanisms could mediate the 
impact of prenatal maternal inflammation on fetal development (Kundakovic & Jaric, 2017). 
Current results based on a screened, physically healthy population of pregnant mothers 
suggested that the association between maternal antenatal cortisol or CRP and infant cognitive 
developmental outcomes behaved in a linear fashion, in line with previous studies showing a dose-
response relationship across the range between prenatal stress and child outcomes (e.g., 
MacKinnon, Kingsbury, Mahedy, Evans & Colman, 2018; Kingston et al., 2018; O’Connor, Heron, 
Golding, Beveridge, & Glover, 2002). Furthermore, it is worth mentioning that the effects we 
reported were independent of a range of maternal pre- and postnatal factors (i.e. concurrent 
depressive or anxiety symptoms, quality of caregiving, IQ), and were not fully explained by infant 
factors (i.e. gender or gestational age). These results strengthen the hypothesis that prenatal 
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maternal stress biology can independently predict individual differences in early infant cognitive 
development. Future studies should investigate the extent to which the observed associations are 
independent of genetic influences, which are likely to confound the associations among prenatal 
factors and child outcomes, by adopting genetically informed designs (Rice, Langley, Woodford, 
Smith, & Thapar, 2018).     
Some non-significant findings are noteworthy. In contrast to our initial hypotheses, maternal 
prenatal depressive or anxiety symptoms were not significantly associated with 3-month-olds’ 
cognitive development. It is possible that the relatively mild levels of maternal depression or 
anxiety symptoms in the current low-risk sample could have limited our ability to detect a significant 
association. However, it is worth mentioning that null findings have also been reported in clinical 
(Osborne et al., 2018; O’Leary et al., 2019) and high-risk samples (Bandoli et al., 2016). 
Additionally, we cannot rule out that the exclusion of pregnant women with chronic medical 
problems or obstetric complications, resulting in a highly selected sample, might have biased the 
observed associations. Alternatively, the effects of maternal prenatal depression or anxiety on 
cognitive outcomes might emerge later in development (e.g., Koutra et al., 2013;  Lin et al., 2017; 
Evans et al., 2012). Interestingly, in line with several studies (e.g., Davis & Sandman, 2010; 
Voegtline et al., 2013), self-reported anxiety or depressive symptoms were also unrelated to 
biomarkers levels. This underscores the importance of combining subjective and objective 
measures of maternal antenatal stress in order to capture the maternal experience (O’ Donnell & 
Meaney, 2017).  
We also found no associations between maternal antenatal sAA levels and infant cognitive 
outcomes. Evidence for a role of maternal antenatal SNS in fetal programming is scarce and, to 
our knowledge, no published data exists on the link between prenatal maternal sAA levels and 
infant cognitive measures. Further replication of this finding in different cohorts is needed before 
strong conclusions can be drawn about the association between sAA and infant cognitive 
outcomes.  
 
4.1 Limitations  
17 
 
The interpretation of our findings should be made with due caution as a result of several 
limitations. First, the results were based on a relatively small middle-high SES community sample 
of healthy women and infants, thus limiting generalizability to different and high-risk populations. 
Secondly, our investigation was limited to one time point in late pregnancy, so the observed 
associations might not extend to other gestational periods. Third, maternal salivary samples were 
collected at home and compliance with the protocol was not objectively measured. Fourth, 
although findings of a prospective association between maternal antenatal factors and offspring 
outcome were in the expected direction and it is tempting to interpret them as suggestive of 
causative biological pathways, they are correlational analyses and no causal conclusions should 
be drawn.  
 
4.2 Conclusion 
The current findings support the view that variations in maternal biological stress signals 
during pregnancy could influence infants’ early cognitive development and encourage further 
investigation into inflammatory mechanisms that have been largely neglected until recently. Early 
performance on the Bayley cognitive scale have been associated with IQ in later childhood (e.g., 
Bode, D'Eugenio, Mettelman, & Gross, 2014) which, in turn, has been related to later academic 
performance and the occurrence of behavioral problems (Boutwell, Helton, Vaughn, & Kavish, 
2017). Thus, the current results might indicate one possible pathway through which prenatal stress 
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Table 1 – Means, Standard Deviations (SD) and Ranges for all study variables  
Study Variable Mean SD Range 
Maternal cortisol (µg/dl)    
Waking 0.38 0.13 0.13-0.83 
Waking +30’  0.50 0.15 0.10-0.91 
Bedtime 0.18 0.06 0.01-0.41 
AUCg 263.92 58.90 83.76-442.71 
Maternal sAA (U/ml)    
Waking 69.89 64.68 3.00-463.84 
Waking +30’  48.33 38.65 2.80-190.10 
Bedtime 97.90 80.39 3.28-562.71 
AUCg 3612.88 690.74 1777.74-5394.20 
Maternal CRP (ng/ml) 3749.61 2714.57 480.04-11179.80 
Maternal IL-6 (pg/ml) 1.69 1.03 0.48-6.47 
Maternal depression (EPDS) 5.34 4.34 0-19 
Maternal anxiety (STAI-S) 34.95 8.63 20-58 
Infant cognitive composite score 102.36 10.81 75-125 
Note: AUCg, Area Under the Curve with respect to the ground; sAA, salivary Alpha Amylase; CRP, C-
Reactive Protein; IL-6, Interleukin-6; EPDS, Edinburgh Postnatal Depression Scale score; STAI-S, State-











Table 2 – Bivariate correlations among study variables  
 
Note: EPDS, Edinburgh Postnatal Depression scale; STAI-S, state subscale of the State-Trait Anxiety 
Inventory; AUCg, area under the curve with respect to the ground; sAA, salivary Alpha Amylase; IL-6, 
Interleukine-6; CRP, C-Reactive Protein. 
 
* p<.05; **p<.01, p>.05 was considered non-significant. 
 
 1 2 3 4 5 6 
1. Prenatal EPDS       
2. Prenatal STAI-S .60**      
3. Prenatal Cortisol AUCg  -.14 .04     
4. Prenatal sAA AUCg  .09 .20 .23*    
5. Prenatal IL-6 .19 .20 .11 .18   
6. Prenatal CRP .06 .13 .09 .01 .30**  
7. Infant Cognitive composite score   -.03 -.09 -.26** -.08 -.07 -.17 
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Table 3 – Hierarchical linear regression analyses predicting 3-month-olds’ cognitive development 
 
 Cognitive composite scores 
 Cortisol AUCg sAA AUCg IL-6 CRP 
 β p β p β p β p 
Step 1:          
Gender .14 .17 .12 .20 .09 .40 .08 .45 
Gestational Age .19 .05 .20 .04 .18 .09 .18 .09 
Maternal IQ .18 .07 .18 .07 .12 .30 .09 .41 
Maternal EA .16 .11 .16 .10 .23 .04 .23 .04 
Postnatal EPDS  .04 .67 .11 .35 .03 .88 .04 .73 
ΔR2 for step 1 .14 .02 .14 .02 .13 .05 .13 .05 
Fmodel 2.89 .02 2.96 .02 2.38 .05 2.37 .05 
Step 2:          
Prenatal EPDS -.15 .21 -.13 .27 -.16 .27 -.14 .28 
ΔR2 for step 2 .01 .21 .01 .27 .01 .24 .01 .28 
Fmodel 2.68 .02 2.68 .02 2.25 .05 2.17 .05 
Step 3:          
Prenatal biomarkers -.37 <.001 -.09 .38 -.01 .95 -.22 .04 
ΔR2 for step 3 .12 <.001 .01 .38 .00 .95 .04 .04 
Fmodel 4.79 <.001 2.41 .03 1.88 .08 2.54 .02 
Note: AUCg, Area Under the Curve with respect to the ground; sAA, salivary Alpha Amylase; CRP, C-















AVAILABILITY OF DATA STATEMENT: The data that support the findings of this study are 
available from the corresponding author upon reasonable request. 
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Note: AUCg, Area Under the Curve with respect to the ground; sAA, salivary Alpha Amylase; CRP, C-Reactive Protein; 
IL-6, Interleukin-6; STAI, State-Trait Anxiety Inventory state anxiety subscale score; EA, Emotional Availability. 
 Cognitive composite scores 
 Cortisol AUCg sAA AUCg IL-6 CRP 
 β p β p β p β p 
Step 1:          
Gender .12 .22 .11 .26 .07 .49 .07 .54 
Gestational Age .19 .06 .19 .05 .17 .10 .17 .10 
Maternal IQ .19 .06 .18 .06 .12 .30 .10 .38 
Maternal EA .14 .15 .15 .13 .21 .05 .22 .05 
Postnatal STAI  .06 .52 .06 .53 .08 .44 .08 .45 
ΔR2 for step 1 .13 .02 .13 .02 .12 .05 .12 .06 
Fmodel 2.76 .02 2.84 .02 2.27 .05 2.25 .06 
Step 2:          
Prenatal STAI -.14 .20 -.13 .22 -.11 .37 -.11 .38 
ΔR2 for step 2 .01 .20 .01 .22 .01 .37 .01 .38 
Fmodel 2.59 .02 2.64 .02 2.02 .07 2.00 .07 
Step 3:          
Prenatal biomarkers -.32 .001 -.06 .57 -.04 .73 -.20 .05 
ΔR2 for step 3 .09 <.001 .00 .57 .00 .73 .04 .05 
Fmodel 4.02 .001 2.29 .03 1.73 .11 2.30 .03 
